Understanding how antibodies interact with HIV to improve vaccine design
Assessing HIV-1 Broadly Neutralizing Antibody Association Pathways for Vaccine Immunogen Design
This study is looking at how antibodies work with HIV-1 to help create better vaccines, aiming to find ways to make vaccines that can trigger strong and lasting immune responses against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10892921 on NIH RePORTER |
What this research studies
This research investigates the complex interactions between antibodies and HIV-1 to enhance vaccine development. By using advanced techniques like molecular simulations and cryo-electron microscopy, the study aims to understand how antibodies bind to HIV-1 antigens. The goal is to identify specific design principles that can lead to more effective vaccines capable of inducing broadly neutralizing antibody responses. This approach focuses on improving the kinetics of antibody-antigen interactions to create better immunogens for vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV-1 infection or those interested in participating in HIV vaccine trials.
Not a fit: Patients who are already HIV-positive or those who do not have a risk of HIV-1 infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against HIV-1, potentially reducing the incidence of the virus.
How similar studies have performed: Previous research has shown promise in using similar approaches to enhance vaccine efficacy, indicating potential for success in this area.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Henderson, Rory — Duke University
- Study coordinator: Henderson, Rory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.